peroxynitrous acid has been researched along with beta-naphthoflavone in 1 studies
Studies (peroxynitrous acid) | Trials (peroxynitrous acid) | Recent Studies (post-2010) (peroxynitrous acid) | Studies (beta-naphthoflavone) | Trials (beta-naphthoflavone) | Recent Studies (post-2010) (beta-naphthoflavone) |
---|---|---|---|---|---|
3,303 | 21 | 1,230 | 1,238 | 0 | 147 |
Protein | Taxonomy | peroxynitrous acid (IC50) | beta-naphthoflavone (IC50) |
---|---|---|---|
Cytochrome P450 1A1 | Homo sapiens (human) | 0.054 | |
Cytochrome P450 1A2 | Homo sapiens (human) | 0.2767 | |
Tyrosine-protein kinase Fyn | Homo sapiens (human) | 2.5149 | |
Mitogen-activated protein kinase 3 | Homo sapiens (human) | 5.4667 | |
Broad substrate specificity ATP-binding cassette transporter ABCG2 | Homo sapiens (human) | 7.185 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
El-Kadi, AO; Gharavi, N | 1 |
1 other study(ies) available for peroxynitrous acid and beta-naphthoflavone
Article | Year |
---|---|
Role of nitric oxide in downregulation of cytochrome P450 1a1 and NADPH: Quinone oxidoreductase 1 by tumor necrosis factor-alpha and lipopolysaccharide.
Topics: Animals; beta-Naphthoflavone; Carcinoma, Hepatocellular; Cell Line, Tumor; Cytochrome P-450 CYP1A1; Dose-Response Relationship, Drug; Down-Regulation; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Inflammation; Lipopolysaccharides; Liver Neoplasms; Lysine; Metalloporphyrins; Mice; NAD(P)H Dehydrogenase (Quinone); NADPH Dehydrogenase; Nitric Oxide; Nitric Oxide Synthase Type II; Peroxynitrous Acid; RNA, Messenger; Time Factors; Tumor Necrosis Factor-alpha | 2007 |